PSMD1 and COVID-19: Assuming the same vaccination schedule for COVID-19, with the stable expression level at 50 mg/L of S1-Fc fusion protein, a 3,000 L CHO cell Bioreactor can easily produce 3 million dose of recombinant S1-Fc vaccine every two weeks.